Royalty Pharma Cash Flow Statement (2019-2025) | RPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)								158.98M	806.75M	221.80M	53.67M	128.08M	491.60M	220.41M	-610.03M	509.09M	351.34M	122.08M	717.59M	-4.27M	194.38M	806.36M	334.35M	433.43M	90.64M	444.21M	355.91M
Gains from Investment Securities (Quarter)								8.71M	8.71M	10.89M	6.54M	3.05M		6.85M		16.27M	-9.70M	-6.57M		13.40M	-2.44M	0.50M	-12.99M		0.60M	0.90M
Cash from Operations (Quarter)								526.10M	531.72M	469.76M	489.96M	460.27M	574.95M	538.83M	569.93M	1,033.84M	607.82M	573.52M	772.63M	664.64M	658.21M	703.61M	742.52M	596.08M	363.98M	702.62M	827.15M
Investing Activities
Capital Expenditures (Quarter)								503.07M	180.67M	1,336.03M	171.73M	0.09M	175.01M	1,316.31M	250.24M	601.71M	60.45M	451.13M	1,002.24M	86.08M	728.63M	1,194.57M	496.42M	1.06M	1.11M	961.87M	733.68M
Acquisitions (Quarter)																										0.23M
Divestments (Quarter)									4.70M	6.20M			6.80M	5.80M		34.77M	2.20M	4.80M	4.66M	4.96M	3.90M	11.00M	3.24M	36.26M	62.40M	0.91M	4.99M
Change in Acquisitions & Divestments (Quarter)								15.62M	853.06M	624.45M	104.72M	274.61M	-243.36M	645.46M	115.64M	24.39M	-24.39M		1.44M	1.44M	2.88M	2.88M	12.59M	12.59M	2.88M	2.88M	-18.35M
Cash from Investing Activities (Quarter)								-599.30M	126.17M	-845.50M	-551.65M	11.16M	-30.18M	-1425.15M	414.74M	-558.53M	-63.43M	-450.66M	-1000.17M	-86.65M	-893.18M	-1192.70M	-505.59M	503.92M	-311.98M	-958.31M	-847.80M
Financing Activities
Other financing activities (Quarter)										12.24M	0.80M								1.60M			3.09M	-21.34M			13.54M	3.02M
Cash from Financing Activities (Quarter)								-226.67M	-224.41M	1,034.27M	-198.07M	-220.97M	-228.25M	-230.09M	-265.55M	-210.37M	-347.00M	-1359.49M	-231.89M	-212.00M	1,156.61M	-325.50M	-257.96M	-941.30M	-507.81M	562.74M	-299.60M
Dividend Payments
Dividends Paid - Common (Quarter)								125.72M	112.48M	125.43M	-230.19M	34.52M	37.83M	38.62M	33.15M	33.39M	30.53M	31.12M	24.49M	32.01M	30.68M	31.02M	31.45M	53.83M	38.60M	34.28M	40.76M
Additional items
Change in Cash (Quarter)								-299.87M	433.47M	658.53M	-259.76M	250.47M	316.52M	-1116.41M	719.12M	264.94M	197.39M	-1236.63M	-459.44M	365.99M	921.64M	-814.59M	-21.03M	158.69M	-455.81M	307.04M	-320.25M
Free Cash Flow (Quarter)								23.03M	351.05M	-866.27M	318.22M	460.19M	399.94M	-777.48M	319.69M	432.13M	547.37M	122.39M	-229.61M	578.55M	-70.42M	-490.96M	246.11M	595.02M	362.87M	-259.26M	93.46M
Net Cash Flow (Quarter)								-299.87M	433.47M	658.53M	-259.76M	250.47M	316.52M	-1116.41M	719.12M	264.94M	197.39M	-1236.63M	-459.44M	365.99M	921.64M	-814.59M	-21.03M	158.69M	-455.81M	307.04M	-320.25M